Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 48 of 151

  1. Dexamethasone

    Kura Oncology

    Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  2. Dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ITP

    phase 2 small molecule active

    1 trial

  3. Dexamethasone

    United Therapeutics Europe Ltd

    Voice Change

    phase 2 small molecule active

    1 trial

  4. Dexamethasone

    Quince Therapeutics

    Nervous System Disorder

    phase 2 small molecule completed

    1 trial

  5. Dexamethasone

    The First People's Hospital of Lianyungang

    Precursor B-Cell Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  6. Dexamethasone Combined with romiplostim N01

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  7. Dexlansoprazole

    Takeda

    Barrett's Esophagus

    phase 2 small molecule terminated

    1 trial

  8. Dexlansoprazole

    Takeda

    Gastroesophageal Reflux Disease (GERD)

    phase 2 small molecule active

    1 trial

  9. Dexmedetomidine

    BioXcel Therapeutics

    Opioid Withdrawal

    phase 2 small molecule completed

    1 trial

  10. Dexmedetomidine

    COGNITION THERAPEUTICS INC

    Alzheimer Disease

    phase 2 small molecule completed

    1 trial

  11. Dexmedetomidine injection

    Sana Biotechnology

    Post Spinal Shivering

    phase 2 small molecule active

    1 trial

  12. Dexmedetomidine sublingual film

    BioXcel Therapeutics

    Delirium

    phase 2 small molecule terminated

    1 trial

  13. Dextro-Amphetamine Sulfate

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  14. Dextroamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    4 trials

  15. Dextromethorphan-Bupropion

    Axsome Therapeutics

    Major Depressive Disorder (MDD)

    phase 2 small molecule active

    1 trial

  16. Diamyd

    Wuhan Createrna Science and Technology Co., Ltd

    Latent Autoimmune Diabetes in Adults (LADA)

    phase 2 small molecule active

    1 trial

  17. Diazepam Buccal Film

    Aquestive Therapeutics

    Epilepsy

    phase 2 small molecule completed

    2 trials

  18. Diazepam Buccal Film 12.5 mg

    Aquestive Therapeutics

    Epilepsy

    phase 2 small molecule completed

    1 trial

  19. Diclofenac

    Atrium Therapeutics

    Wobenzym

    phase 2 small molecule completed

    1 trial

  20. Dietary

    The University of Hong Kong

    Colorectal Cancer

    phase 2 other active

    1 trial

  21. Dimethyl fumarate

    Xuanwu Hospital, Beijing

    Intracerebral Hemorrhage

    phase 2 small molecule terminated

    1 trial

  22. Dinutuximab

    Children's Hospital of Fudan University

    High Risk Neuroblastoma

    phase 2 mab active

    1 trial

  23. Dinutuximab

    United Therapeutics Europe Ltd

    Ganglioneuroblastoma

    phase 2 mab completed

    1 trial

  24. Dipraglurant

    Addex Therapeutics

    Blepharospasm

    phase 2 small molecule completed

    1 trial

  25. Disitamab Vedotin

    The First People's Hospital of Lianyungang

    HER2-positive Gastric Cancer

    phase 2 small molecule active

    1 trial

  26. Disitamab Vedotin

    Pfizer Australia Pty Ltd

    HER2 Expressing Advanced Breast Cancer

    phase 2 small molecule active

    1 trial

  27. Disitamab Vedotin (RC48)

    The First People's Hospital of Lianyungang

    Upper Tract Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  28. Disulfiram

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    2 trials

  29. Disulfiram

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol-Related Disorders

    phase 2 small molecule completed

    1 trial

  30. Diuretics

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 2 small molecule completed

    1 trial

  31. Divalproex Sodium (Depakote)

    BRIGHT MINDS BIOSCIENCES INC.

    Mood Disorders

    phase 2 small molecule completed

    1 trial

  32. Docetaxel

    BRIGHT MINDS BIOSCIENCES INC.

    Prostatic Neoplasms

    phase 2 small molecule completed

    1 trial

  33. Docetaxel

    Karyopharm Therapeutics Inc

    Recurrent Squamous Cell Lung Carcinoma

    phase 2 small molecule terminated

    1 trial

  34. Docetaxel

    Merck KGaA, Darmstadt, Germany

    Castration-Resistant Prostatic Cancer

    phase 2 small molecule active

    1 trial

  35. Docetaxel

    Takeda

    Non-small Cell Lung Cancer

    phase 2 small molecule terminated

    1 trial

  36. Docetaxel

    Hospital Authority, Hong Kong

    Non Small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial

  37. Docetaxel + Sunitinib

    Samsung Bioepis NL B.V.

    Advanced Gastric Cancer

    phase 2 small molecule completed

    1 trial

  38. Docetaxel, Reolysin and Prednisone

    ONCOLYTICS BIOTECH INC

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  39. Dociparstat sodium

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  40. Domvanalimab

    Arcus Biosciences

    Advanced Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  41. Domvanalimab

    Arcus Biosciences

    Non Small Cell Lung Cancer

    phase 2 small molecule active

    2 trials

  42. Domvanalimab

    Arcus Biosciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  43. Domvanalimab

    Arcus Biosciences

    Gastrointestinal Tract Malignancies

    phase 2 small molecule active

    1 trial

  44. Donafenib + Envafolimab

    Anhui Provincial Hospital

    Hepatocellular Carcinoma

    phase 2 small molecule active

    1 trial

  45. Donanemab

    Eli Lilly and Company

    Cognitive Dysfunction

    phase 2 small molecule active

    1 trial

  46. Donepezil Hydrochloride

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Radiation Injuries

    phase 2 small molecule active

    1 trial

  47. Dopacis 90 MBq/ml oplossing voor injectie

    CERO THERAPEUTICS HOLDINGS, INC.

    patients with newly discovered brain metastases (non-small cell lung cancer, breast cancer or melanoma) measuring more than 5 mm and explored on MRI

    phase 2 small molecule active

    1 trial

  48. Doravirine

    Merck KGaA, Darmstadt, Germany

    Human Immunodeficiency Virus (HIV) Infection

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.